Physicians at the University of Wisconsin School of Medicine and Public Health authored papers showing that the Sanofi-Aventis drug Multaq is an excellent treatment for atrial fibrillation. Now, however, it appears that Multaq may be dangerous, and the authors apparently never saw the raw data that they vouched for. They did get large checks from Sanofi-Aventis, though. Read more in the Milwaukee Journal-Sentinel.
No comments:
Post a Comment